-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on AVITA Medical, Raises Price Target to $20

Benzinga·11/07/2026 01:35:01
Listen to the news
Lake Street analyst Frank Takkinen maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $12 to $20.